Sfoglia per SSD
Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: A population-based cohort study in Italy
2014 S. Cammarota, D. Bruzzese, A. Catapano, A. Citarella, L. De Luca, L. Manzoli, M. Masulli, E. Menditto, A. Mezzetti, S. Riegler, D. Putignano, E. Tragni, E. Novellino, G. Riccardi
Lower Rate of Cardiovascular Complications in Patients on Bolus Insulin Analogues : a Retrospective Population-Based Cohort Study
2013 S. Cammarota, L.M. Falconio, D. Bruzzese, A.L. Catapano, M. Casula, A. Citarella, L. De Luca, M.E. Flacco, L. Manzoli, M. Masulli, E. Menditto, A. Mezzetti, S. Riegler, E. Novellino, G. Riccardi
LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy
2012 F. Amati, L. Diano, L. Vecchione, G.D. Norata, Y. Koyama, L. Cutuli, A.L. Catapano, F. Romeo, H. Ando, G. Novelli
LOX-1, OxLDL, and atherosclerosis
2013 A. Pirillo, G.D. Norata, A.L. Catapano
LPS-matured CD11c+ bone marrow-derived dendritic cells can initiate autoimmune pathology with minimal injection site inflammation
2017 L. Saul, D. Besusso, R.J. Mellanby
LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool
2011 G. Piccoli, S.B. Condliffe, M. Bauer, F. Giesert, K. Boldt, S. De Astis, A. Meixner, H. Sarioglu, D.M. Vogt-Weisenhorn, W. Wurst, C.J. Gloeckner, M. Matteoli, C. Sala, M. Ueffing
LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex
2014 M.D. Cirnaru, A. Marte, E. Belluzzi, I. Russo, M. Gabrielli, F. Longo, L. Arcuri, L. Murru, L. Bubacco, M. Matteoli, E. Fedele, C. Sala, M. Passafaro, M. Morari, E. Greggio, F. Onofri, G. Piccoli
LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesias
2016 J. Stanic, M. Mellone, M.D. Cirnaru, M. Perez-Carrion, E. Zianni, M.M.G. Di Luca, F. Gardoni, G. Piccoli
LSD1 is an environmental stress-sensitive negative modulator of the glutamatergic synapse
2020 A. Longaretti, C. Forastieri, E. Toffolo, L. Caffino, A. Locarno, I. Miseviciute, E. Marchesi, M. Battistin, L. Ponzoni, L. Madaschi, C. Cambria, M.P. Bonasoni, M. Sala, D. Perrone, F. Fumagalli, S. Bassani, F. Antonucci, R. Tonini, M. Francolini, E. Battaglioli, F. Rusconi
LSD1 neurospecific alternative splicing controls neuronal excitability in mouse models of epilepsy
2015 F. Rusconi, L. Paganini, D. Braida, L. Ponzoni, E. Toffolo, A. Maroli, N. Landsberger, F. Bedogni, E. Turco, L. Pattini, F. Altruda, S. De Biasi, M. Sala, E. Battaglioli
LT175 is a novel PPARα/γ ligand with potent insulin sensitizing effects and reduced adipogenic properties
2014 F. Gilardi, M. Giudici, N. Mitro, O. Maschi, U. Guerrini, G. Rando, A. Maggi, G. Cermenati, A. Laghezza, F. Loiodice, G. Pochetti, A. Lavecchia, D. Caruso, E. De Fabiani, K. Bamberg, M. Crestani
LT175, a dual PPAR ligand, increases energy metabolism and improves the diabetic phenotype in different mouse models
2010 M. Giudici, F. Gilardi, N. Mitro, F. Loiodice, G. Pochetti, A. Lavecchia, A. Maggi, E. De Fabiani, D. Caruso, M. Crestani
Luciferase reporter expression in transgenic mice
2005 A. Maggi
Lupin (Lupinus albus) protein isolate (L-ISO) has adequate nutritional value and reduces large intestinal weight in rats after restricted and ad libitum feeding
2006 S. Caligari, G. Chiesa, S. K. Johnson, D. Camisassi, D. Gilio, M. Marchesi, C. Parolini, L. A. Rubio, C. R. Sirtori
Lupin Peptide T9 (GQEQSHQDEGVIVR) Modulates the Mutant PCSK9D374Y Pathway : in vitro Characterization of its Dual Hypocholesterolemic Behavior
2019 C. Lammi, C. Bollati, D. Lecca, M.P. Abbracchio, A. Arnoldi
Lupin protein (Lupinus albus) intake decrease blood pressure and other cardiovascular risk factors in smokers. A pilot study
2007 M. Naruszewicz, G. Nowicka, L. Kosiewicz Latoszek, A. Arnoldi, C. Sirtori
Lupin protein : a new source of cardiovascular protective agents?
2006 G. Chiesa, S.K. Johnson, M. Marchesi, C. Parolini, S. Caligari, D. Gilio, L. Cornelli, E. Diani, E. Rigamonti, C. Sirtori
Lupin protein exerts cholesterol-lowering effects targeting PCSK9: from clinical evidences to elucidation of the in vitro molecular mechanism using HepG2 cells
2016 C. Lammi, C. Zanoni, L. Calabresi, A. Arnoldi
Lupin proteins in the treatment of hypercholesterolemia
2006 G. Nowicka, L. KLOSIEWICZ LATOSZEK, C.R. Sirtori, A. Arnoldi, M. Naruszewicz
Lupin proteins reduce progression of a focal atheromatous lesion in rabbits
2006 C. Parolini, S.K. Johnson, M. Marchesi, E. Diani, E. Rigamonti, L. Cornelli, C.R. Sirtori, G. Chiesa
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile